SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), in an effort to further constantly develop Avant! which is held by GBT Tokenize LLC (“GBT ...
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it intends to offer $250.0 million aggregate principal amount of ...
While the path to commercialization requires additional research, development, and strategic partnerships for successful market introduction, both Bannix and VisionWave are confident in the ...
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced it has entered into an agreement with Sanofi S.A. to exclusively ...
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that an expanded access protocol (EAP) for Oxbryta® (voxelotor) in ...
The $6.3 billion take-private acquisition of Amex GBT by Long Lake Management, announced Monday, is the largest corporate travel deal in years. It’s also the final chapter of an ownership saga that ...